Re: Phase 1b/2 trial expected to initiate 1Q 2019

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Phase 1b/2 trial expected to initiate 1Q 2019

in response to

Phase 1b/2 trial expected to initiate 1Q 2019

BearDownAZ

posted on Mar 13, 2019 09:23AM

Bear,

This is a pretty long delay to get things started on this trial with Pfizer, you would think they would want to move quickly with the start of this trial .... I wonder if more important things are getting finalized before they commence this trial, just thinking out loud.....

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply